Albumedix announces recombinant human albumin supply partnership with FUJIFILM Wako Pure Chemical Corporation for the Japanese, Chinese and Hong Kong markets
Nottingham, UK – 29th March 2021 – Life Science Newswire – Albumedix Ltd.
(‘Albumedix’), an enabler of advanced therapies and world leader in
recombinant human albumin (rHA), announced today that they have entered
into a distribution agreement with established and well recognized
reagent supplier FUJIFILM Wako Pure Chemical Corporation (FUJIFILM Wako)
in Japan and China including Hong Kong.
More info >> |